CD151 and squamous cell carcinoma: Utilizing wild type or CD151 ablated A431 epidermoid carcinoma cells, it was shown that the loss of CD151 reduces STAT3 activation in response to 12-O-Tetradecanoylphorbol-13-acetate (TPA) stimulation, which is another known activator of PKCα.